Top

The International Journal of Cardiovascular Imaging

Published in:

01-08-2019 | Review Paper

Advanced imaging in pulmonary hypertension: emerging techniques and applications

Authors: Fabian Rengier, Claudius Melzig, Thorsten Derlin, Alberto M. Marra, Jens Vogel-Claussen

Published in: The International Journal of Cardiovascular Imaging | Issue 8/2019

Abstract

Pulmonary hypertension (PH) is a pathophysiological disorder defined by an increase in pulmonary arterial pressure which can occur in multiple clinical conditions. Irrespective of etiology, PH entails a negative impact on exercise capacity and quality of life, and is associated with high mortality particularly in pulmonary arterial hypertension. Noninvasive imaging techniques play an important role in suggesting the presence of PH, providing noninvasive pulmonary pressure measurements, classifying the group of PH, identifying a possibly underlying disease, providing prognostic information and assessing response to treatment. While echocardiography, computed tomography (CT) and ventilation/perfusion scans are an integral part of routine work-up of patients with suspected PH according to current guidelines and across centers, innovative new techniques and applications in the field of PH such as 3D echocardiography, dual-energy CT, 4D flow magnetic resonance imaging (MRI), T1 and extracellular volume fraction mapping, non-contrast-enhanced MRI sequences for perfusion and ventilation assessment, and molecular-targeted positron emission tomography are emerging. This review discusses advanced and emerging imaging techniques in diagnosis, prognostic evaluation and follow-up of patients with PH.

Galiè N, Humbert M, Vachiery J-L et al (2015) ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 46(4):903–975CrossRefPubMed

D’Alonzo GE, Barst RJ, Ayres SM et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115(5):343–349CrossRefPubMed

Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S (2007) Pathology of pulmonary hypertension. Clin Chest Med 28(1):23–42 viiCrossRefPubMedPubMedCentral

van Riel ACMJ, Opotowsky AR, Santos M et al (2017) Accuracy of echocardiography to estimate pulmonary artery pressures with exercise: a simultaneous invasive-noninvasive comparison. Circ Cardiovasc Imaging 10(4):e005711PubMedPubMedCentral

Coghlan JG, Denton CP, Grünig E et al (2014) Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 73(7):1340–1349CrossRefPubMed

Marra AM, Egenlauf B, Ehlken N et al (2015) Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Int J Cardiol 195:19–26CrossRefPubMed

van de Veerdonk MC, Marcus JT, Westerhof N et al (2015) Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension. Chest 147(4):1063–1071CrossRefPubMed

Batal O, Dardari Z, Costabile C, Gorcsan J, Arena VC, Mathier MA (2015) Prognostic value of pericardial effusion on serial echocardiograms in pulmonary arterial hypertension. Echocardiography 32(10):1471–1476CrossRefPubMed

Kylhammar D, Kjellström B, Hjalmarsson C et al (2017) A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J. https://doi.org/10.1093/eurheartj/ehx257 CrossRef

10.

Hoeper MM, Kramer T, Pan Z et al (2017) Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 50(2):1700740CrossRefPubMed

11.

Grünig E, Tiede H, Enyimayew EO et al (2013) Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation 128(18):2005–2015CrossRefPubMed

12.

Ferrara F, Gargani L, Ostenfeld E et al (2017) Imaging the right heart pulmonary circulation unit: insights from advanced ultrasound techniques. Echocardiography 34(8):1216–1231CrossRefPubMed

13.

Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685–713 quiz 786–788CrossRefPubMed

14.

Bhave NM, Patel AR, Weinert L et al (2013) Three-dimensional modeling of the right ventricle from two-dimensional transthoracic echocardiographic images: utility of knowledge-based reconstruction in pulmonary arterial hypertension. J Am Soc Echocardiogr 26(8):860–867CrossRefPubMed

15.

Grapsa J, O’Regan DP, Pavlopoulos H, Durighel G, Dawson D, Nihoyannopoulos P (2010) Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur J Echocardiogr 11(1):64–73CrossRefPubMed

16.

Li Y, Wang Y, Zhai Z, Guo X, Yang Y, Lu X (2015) Real-time three-dimensional echocardiography to assess right ventricle function in patients with pulmonary hypertension. PLoS ONE 10(6):e0129557CrossRefPubMedPubMedCentral

17.

Bossone E, Ferrara F, Grünig E (2015) Echocardiography in pulmonary hypertension. Curr Opin Cardiol 30(6):574–586CrossRefPubMed

18.

Leibundgut G, Rohner A, Grize L et al (2010) Dynamic assessment of right ventricular volumes and function by real-time three-dimensional echocardiography: a comparison study with magnetic resonance imaging in 100 adult patients. J Am Soc Echocardiogr 23(2):116–126CrossRefPubMed

19.

Gerges M, Gerges C, Lang IM (2015) Advanced imaging tools rather than hemodynamics should be the primary approach for diagnosing, following, and managing pulmonary arterial hypertension. Can J Cardiol 31(4):521–528CrossRefPubMed

20.

Grünig E, Peacock AJ (2015) Imaging the heart in pulmonary hypertension: an update. Eur Respir Rev 24(138):653–664CrossRefPubMed

21.

D’Alto M, Romeo E, Argiento P et al (2015) Pulmonary arterial hypertension: the key role of echocardiography. Echocardiography 32(Suppl 1):S23–S37CrossRefPubMed

22.

Haeck MLA, Scherptong RWC, Marsan NA et al (2012) Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension. Circ Cardiovasc Imaging 5(5):628–636CrossRefPubMed

23.

Sachdev A, Villarraga HR, Frantz RP et al (2011) Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest 139(6):1299–1309CrossRefPubMed

24.

Greiner S, André F, Heimisch M et al (2013) Non-invasive quantification of right ventricular systolic function by echocardiography: a new semi-automated approach. Clin Res Cardiol 102(3):229–235CrossRefPubMed

25.

Vitarelli A, Mangieri E, Terzano C et al (2015) Three-dimensional echocardiography and 2D-3D speckle-tracking imaging in chronic pulmonary hypertension: diagnostic accuracy in detecting hemodynamic signs of right ventricular (RV) failure. J Am Heart Assoc 4(3):e001584CrossRefPubMedPubMedCentral

26.

Truong QA, Massaro JM, Rogers IS et al (2012) Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging 5(1):147–154CrossRefPubMed

27.

Shen Y, Wan C, Tian P et al (2014) CT-base pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review. Medicine (Baltimore) 93(27):e256CrossRef

28.

Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW (1998) Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group. Chest 113(5):1250–1256CrossRefPubMed

29.

Rajaram S, Swift AJ, Capener D et al (2012) Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. J Rheumatol 39(6):1265–1274CrossRefPubMed

30.

Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM (2010) Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 254(2):609–616CrossRefPubMed

31.

Tanabe Y, Landeras L, Ghandour A, Partovi S, Rajiah P (2018) State-of-the-art pulmonary arterial imaging—part 1. VASA 47:345–359CrossRefPubMed

32.

Goerne H, Chaturvedi A, Partovi S, Rajiah P (2018) State-of-the-art pulmonary arterial imaging—part 2. VASA 47:361–375CrossRefPubMed

33.

Biesdorf A, Rohr K, Feng D et al (2012) Segmentation and quantification of the aortic arch using joint 3D model-based segmentation and elastic image registration. Med Image Anal 16(6):1187–1201CrossRefPubMed

34.

Linguraru MG, Pura JA, Van Uitert RL et al (2010) Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension. Med Phys 37(4):1522–1532CrossRefPubMedPubMedCentral

35.

Froelich JJ, Koenig H, Knaak L, Krass S, Klose KJ (2008) Relationship between pulmonary artery volumes at computed tomography and pulmonary artery pressures in patients with- and without pulmonary hypertension. Eur J Radiol 67(3):466–471CrossRefPubMed

36.

Melzig C, Wörz S, Egenlauf B et al (2017) B-0570 - Non-invasive estimation of mean pulmonary arterial pressure in suspected pulmonary hypertension based on automated 3D volumetry of pulmonary CT angiography. SS 704 - Pulmonary vessels and perfusion, European Congress of Radiology, Vienna

37.

Jivraj K, Bedayat A, Sung YK et al (2017) Left atrium maximal axial cross-sectional area is a specific computed tomographic imaging biomarker of World Health Organization Group 2 pulmonary hypertension. J Thorac Imaging 32(2):121–126CrossRefPubMed

38.

Currie BJ, Johns C, Chin M et al (2018) CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: derivation and validation of predictive thresholds. Int J Cardiol 260:172–177CrossRefPubMedPubMedCentral

39.

Aviram G, Rozenbaum Z, Ziv-Baran T et al (2017) Identification of pulmonary hypertension caused by left-sided heart disease (World Health Organization Group 2) based on cardiac chamber volumes derived from chest CT imaging. Chest 152(4):792–799CrossRefPubMed

40.

Nakazawa T, Watanabe Y, Hori Y et al (2011) Lung perfused blood volume images with dual-energy computed tomography for chronic thromboembolic pulmonary hypertension: correlation to scintigraphy with single-photon emission computed tomography. J Comput Assist Tomogr 35(5):590–595CrossRefPubMed

41.

Hachulla A-L, Lador F, Soccal PM, Montet X, Beghetti M (2016) Dual-energy computed tomographic imaging of pulmonary hypertension. Swiss Med Wkly 146:w14328PubMed

42.

Koike H, Sueyoshi E, Sakamoto I, Uetani M, Nakata T, Maemura K (2018) Comparative clinical and predictive value of lung perfusion blood volume CT, lung perfusion SPECT and catheter pulmonary angiography images in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty. Eur Radiol. https://doi.org/10.1007/s00330-018-5501-4 CrossRefPubMed

43.

Ameli-Renani S, Ramsay L, Bacon JL et al (2014) Dual-energy computed tomography in the assessment of vascular and parenchymal enhancement in suspected pulmonary hypertension. J Thorac Imaging 29(2):98–106CrossRefPubMed

44.

Leithner D, Wichmann JL, Vogl TJ et al (2017) Virtual monoenergetic imaging and iodine perfusion maps improve diagnostic accuracy of dual-energy computed tomography pulmonary angiography with suboptimal contrast attenuation. Invest Radiol 52(11):659–665CrossRefPubMed

45.

McLure LER, Peacock AJ (2009) Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. Eur Respir J 33(6):1454–1466CrossRefPubMed

46.

Grothues F, Smith GC, Moon JCC et al (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90(1):29–34CrossRefPubMed

47.

Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER et al (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17:29CrossRefPubMedPubMedCentral

48.

Swift AJ, Capener D, Johns C et al (2017) Magnetic resonance imaging in the prognostic evaluation of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 196(2):228–239CrossRefPubMedPubMedCentral

49.

van Wolferen SA, Marcus JT, Boonstra A et al (2007) Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 28(10):1250–1257CrossRefPubMed

50.

Peacock AJ, Crawley S, McLure L et al (2014) Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging 7(1):107–114CrossRefPubMed

51.

Freed BH, Collins JD, François CJ et al (2016) MR and CT imaging for the evaluation of pulmonary hypertension. JACC Cardiovasc Imaging 9(6):715–732CrossRefPubMedPubMedCentral

52.

Roeleveld RJ, Marcus JT, Faes TJC et al (2005) Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 234(3):710–717CrossRefPubMed

53.

Swift AJ, Rajaram S, Hurdman J et al (2013) Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. JACC Cardiovasc Imaging 6(10):1036–1047CrossRefPubMed

54.

Johns CS, Rajaram S, Capener DA et al (2018) Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging. Eur Radiol 28(4):1438–1448CrossRefPubMed

55.

Shehata ML, Cheng S, Osman NF, Bluemke DA, Lima JAC (2009) Myocardial tissue tagging with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:55CrossRefPubMedPubMedCentral

56.

Shehata ML, Basha TA, Tantawy WH et al (2010) Real-time single-heartbeat fast strain-encoded imaging of right ventricular regional function: normal versus chronic pulmonary hypertension. Magn Reson Med 64(1):98–106CrossRefPubMedPubMedCentral

57.

Shehata ML, Harouni AA, Skrok J et al (2013) Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. Radiology 266(1):114–122CrossRefPubMedPubMedCentral

58.

Maschke SK, Schoenfeld CO, Kaireit TF et al (2018) MRI-derived regional biventricular function in patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy. Acad Radiol. https://doi.org/10.1016/j.acra.2018.04.002 CrossRefPubMed

59.

Barker AJ, Roldán-Alzate A, Entezari P et al (2015) Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions. Magn Reson Med 73(5):1904–1913CrossRefPubMed

60.

Delles M, Rengier F, Azad Y-J et al (2015) Non-invasive pulmonary blood flow analysis and blood pressure mapping derived from 4D flow MRI. Proc SPIE 9417:94172GCrossRef

61.

Rengier F, Delles M, Eichhorn J et al (2015) Noninvasive 4D pressure difference mapping derived from 4D flow MRI in patients with repaired aortic coarctation: comparison with young healthy volunteers. Int J Cardiovasc Imaging 31(4):823–830CrossRefPubMed

62.

Reiter G, Reiter U, Kovacs G, Olschewski H, Fuchsjäger M (2015) Blood flow vortices along the main pulmonary artery measured with MR imaging for diagnosis of pulmonary hypertension. Radiology 275(1):71–79CrossRefPubMed

63.

Rengier F, Geisbüsch P, Schoenhagen P et al (2014) State-of-the-art aortic imaging: part II—applications in transcatheter aortic valve replacement and endovascular aortic aneurysm repair. VASA 43(1):6–26CrossRefPubMed

64.

Tang BT, Pickard SS, Chan FP, Tsao PS, Taylor CA, Feinstein JA (2012) Wall shear stress is decreased in the pulmonary arteries of patients with pulmonary arterial hypertension: an image-based, computational fluid dynamics study. Pulm Circ 2(4):470–476CrossRefPubMedPubMedCentral

65.

Kheyfets VO, Rios L, Smith T et al (2015) Patient-specific computational modeling of blood flow in the pulmonary arterial circulation. Comput Methods Progr Biomed 120(2):88–101CrossRef

66.

Vogel-Claussen J, Rochitte CE, Wu KC et al (2006) Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 26(3):795–810CrossRefPubMed

67.

Shehata ML, Lossnitzer D, Skrok J et al (2011) Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am J Roentgenol 196(1):87–94CrossRefPubMedPubMedCentral

68.

Bessa LGP, Junqueira FP, Bandeira MLDS et al (2013) Pulmonary arterial hypertension: use of delayed contrast-enhanced cardiovascular magnetic resonance in risk assessment. Arq Bras Cardiol 101(4):336–343PubMedPubMedCentral

69.

Junqueira FP, Macedo R, Coutinho AC et al (2009) Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: evaluation by cardiac MRI. Br J Radiol 82(982):821–826CrossRefPubMed

70.

Sanz J, Dellegrottaglie S, Kariisa M et al (2007) Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol 100(4):731–735CrossRefPubMed

71.

McCann GP, Gan CT, Beek AM, Niessen HWM, Vonk Noordegraaf A, van Rossum AC (2007) Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. AJR Am J Roentgenol 188(2):349–355CrossRefPubMed

72.

McLaughlin VV, Sitbon O, Badesch DB et al (2005) Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 25(2):244–249CrossRefPubMed

73.

Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19(1):75CrossRefPubMedPubMedCentral

74.

Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52(1):141–146CrossRefPubMed

75.

Messroghli DR, Walters K, Plein S et al (2007) Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 58(1):34–40CrossRefPubMed

76.

Mehta BB, Chen X, Bilchick KC, Salerno M, Epstein FH (2015) Accelerated and navigator-gated look-locker imaging for cardiac T1 estimation (ANGIE): development and application to T1 mapping of the right ventricle. Magn Reson Med 73(1):150–160CrossRefPubMed

77.

Mehta BB, Auger DA, Gonzalez JA et al (2015) Detection of elevated right ventricular extracellular volume in pulmonary hypertension using accelerated and navigator-gated look-locker imaging for cardiac T1 estimation (ANGIE) cardiovascular magnetic resonance. J Cardiovasc Magn Reson 17:110CrossRefPubMedPubMedCentral

78.

Roller FC, Wiedenroth C, Breithecker A et al (2017) Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension. Eur Radiol 27(5):1980–1991CrossRefPubMed

79.

García-Álvarez A, García-Lunar I, Pereda D et al (2015) Association of myocardial T1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension. JACC Cardiovasc Imaging 8(1):76–82CrossRefPubMed

80.

Partovi S, Aschwanden M, Staub D et al (2011) Gadofosveset enhanced MR phlebography for detecting pelvic and deep vein leg thrombosis. VASA 40(4):315–319CrossRefPubMed

81.

Stein PD, Chenevert TL, Fowler SE et al (2010) Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152(7):434–443 W142–W143CrossRefPubMedPubMedCentral

82.

Sostman HD, Jablonski KA, Woodard PK et al (2012) Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III. Int J Cardiovasc Imaging 28(2):303–312CrossRefPubMed

83.

Pengo V, Lensing AWA, Prins MH et al (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350(22):2257–2264CrossRefPubMed

84.

Olsson KM, Meyer B, Hinrichs J, Vogel-Claussen J, Hoeper MM, Cebotari S (2014) Chronic thromboembolic pulmonary hypertension. Dtsch Arztebl Int 111(50):856–862PubMedPubMedCentral

85.

Ohno Y, Koyama H, Yoshikawa T et al (2012) Contrast-enhanced multidetector-row computed tomography vs. time-resolved magnetic resonance angiography vs. contrast-enhanced perfusion MRI: assessment of treatment response by patients with inoperable chronic thromboembolic pulmonary hypertension. J Magn Reson Imaging 36(3):612–623CrossRefPubMed

86.

Sourbron S, Luypaert R, Morhard D, Seelos K, Reiser M, Peller M (2007) Deconvolution of bolus-tracking data: a comparison of discretization methods. Phys Med Biol 52(22):6761–6778CrossRefPubMed

87.

Hueper K, Parikh MA, Prince MR et al (2013) Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study. Invest Radiol 48(4):223–230PubMedPubMedCentral

88.

Schoenfeld C, Cebotari S, Hinrichs J et al (2016) MR imaging-derived regional pulmonary parenchymal perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy. Radiology 279(3):925–934CrossRefPubMed

89.

Prybylski JP, Semelka RC, Jay M (2017) The stability of gadolinium-based contrast agents in human serum: a reanalysis of literature data and association with clinical outcomes. Magn Reson Imaging 38:145–151CrossRefPubMed

90.

Huckle JE, Altun E, Jay M, Semelka RC (2016) Gadolinium deposition in humans: when did we learn that gadolinium was deposited in vivo? Invest Radiol 51(4):236–240CrossRefPubMed

91.

Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB, International Society for Magnetic Resonance in Medicine (2017) Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 16(7):564–570CrossRefPubMed

92.

Rengier F, Geisbüsch P, Vosshenrich R et al (2013) State-of-the-art aortic imaging: part I—fundamentals and perspectives of CT and MRI. VASA 42(6):395–412CrossRefPubMed

93.

Edelman RR, Silvers RI, Thakrar KH et al (2017) Nonenhanced MR angiography of the pulmonary arteries using single-shot radial quiescent-interval slice-selective (QISS): a technical feasibility study. J Cardiovasc Magn Reson 19(1):48CrossRefPubMedPubMedCentral

94.

Bannas P, Bell LC, Johnson KM et al (2016) Pulmonary embolism detection with three-dimensional ultrashort echo time MR imaging: experimental study in canines. Radiology 278(2):413–421CrossRefPubMed

95.

Bauman G, Puderbach M, Deimling M et al (2009) Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med 62(3):656–664CrossRefPubMed

96.

Voskrebenzev A, Gutberlet M, Becker L, Wacker F, Vogel-Claussen J (2016) Reproducibility of fractional ventilation derived by Fourier decomposition after adjusting for tidal volume with and without an MRI compatible spirometer. Magn Reson Med 76(5):1542–1550CrossRefPubMed

97.

Fischer A, Weick S, Ritter CO et al (2014) SElf-gated non-contrast-enhanced functional lung imaging (SENCEFUL) using a quasi-random fast low-angle shot (FLASH) sequence and proton MRI. NMR Biomed 27(8):907–917CrossRefPubMed

98.

Bauman G, Lützen U, Ullrich M et al (2011) Pulmonary functional imaging: qualitative comparison of Fourier decomposition MR imaging with SPECT/CT in porcine lung. Radiology 260(2):551–559CrossRefPubMed

99.

Bauman G, Scholz A, Rivoire J et al (2013) Lung ventilation- and perfusion-weighted Fourier decomposition magnetic resonance imaging: in vivo validation with hyperpolarized 3He and dynamic contrast-enhanced MRI. Magn Reson Med 69(1):229–237CrossRefPubMed

100.

Schönfeld C, Cebotari S, Voskrebenzev A et al (2015) Performance of perfusion-weighted Fourier decomposition MRI for detection of chronic pulmonary emboli. J Magn Reson Imaging 42(1):72–79CrossRefPubMed

101.

Fedullo PF, Auger WR, Kerr KM, Rubin LJ (2001) Chronic thromboembolic pulmonary hypertension. N Engl J Med 345(20):1465–1472CrossRefPubMed

102.

Tunariu N, Gibbs SJR, Win Z et al (2007) Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 48(5):680–684CrossRefPubMed

103.

Lu Y, Lorenzoni A, Fox JJ et al (2014) Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism. Chest 145(5):1079–1088CrossRefPubMed

104.

Derlin T, Kelting C, Hueper K et al (2018) Quantitation of perfused lung volume using hybrid SPECT/CT allows refining the assessment of lung perfusion and estimating disease extent in chronic thromboembolic pulmonary hypertension. Clin Nucl Med 43(6):e170–e177PubMed

105.

Burger IA, Husmann L, Herzog BA et al (2011) Main pulmonary artery diameter from attenuation correction CT scans in cardiac SPECT accurately predicts pulmonary hypertension. J Nucl Cardiol 18(4):634–641CrossRefPubMed

106.

Wang L, Li W, Yang Y et al (2016) Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study. Eur Heart J Cardiovasc Imaging 17(10):1161–1168CrossRefPubMed

107.

Oikawa M, Kagaya Y, Otani H et al (2005) Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 45(11):1849–1855CrossRefPubMed

108.

Saygin D, Highland KB, Farha S et al (2017) Metabolic and functional evaluation of the heart and lungs in pulmonary hypertension by gated 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography. Pulm Circ 7(2):428–438CrossRefPubMedPubMedCentral

109.

Kluge R, Barthel H, Pankau H et al (2005) Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med 46(1):25–31PubMed

110.

Tatebe S, Fukumoto Y, Oikawa-Wakayama M et al (2014) Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study. Eur Heart J Cardiovasc Imaging 15(6):666–672CrossRefPubMed

111.

Fang W, Zhao L, Xiong C-M et al (2012) Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease. Pulm Circ 2(3):365–372CrossRefPubMedPubMedCentral

112.

Zhao L, Ashek A, Wang L et al (2013) Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. Circulation 128(11):1214–1224CrossRefPubMed

113.

Marsboom G, Wietholt C, Haney CR et al (2012) Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med 185(6):670–679CrossRefPubMedPubMedCentral

114.

Ohira H, de Kemp R, Pena E et al (2016) Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response. Eur Heart J Cardiovasc Imaging 17(12):1424–1431CrossRefPubMed

Title: Advanced imaging in pulmonary hypertension: emerging techniques and applications
Authors: Fabian Rengier
Claudius Melzig
Thorsten Derlin
Alberto M. Marra
Jens Vogel-Claussen
Publication date: 01-08-2019
Publisher: Springer Netherlands
Published in: The International Journal of Cardiovascular Imaging / Issue 8/2019
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-018-1448-4

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Advanced imaging in pulmonary hypertension: emerging techniques and applications

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2019

Role of cardiovascular magnetic resonance end-systolic 3D-SSFP sequence in repaired tetralogy of Fallot patients eligible for transcatheter pulmonary valve implantation

3D-assessment of RVOT dimensions prior percutaneous pulmonary valve implantation: comparison of contrast-enhanced magnetic resonance angiography versus 3D steady-state free precession sequence

Feasibility and utility of dual-energy chest CTA for preoperative planning in pediatric pulmonary artery reconstruction

Imaging and Surgical Treatment of Primary Pulmonary Artery Sarcoma

Cross-sectional imaging of congenital pulmonary artery anomalies

Computed tomography-measured pulmonary artery to aorta ratio and EUTOS score for detecting dasatinib-induced pulmonary arterial hypertension

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page